Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Coppock Curve
WATCH VIDEO - CLICK HERE <-
Learn all aspects of trading penny stocks in Chart School, Videos include;
Accumulation Distribution
ADX - Average Directional Index
Aroon
ATR - Average True Range
Bollinger %B
Bollinger Band Width
CCI - Commodity Channel Index
Chaikin Oscillator
CMF - Chaikin Money Flow
Coppock Curve
Correlation Coefficient
EMV- Ease of Movement
Fibonacci Retracement
Force Index
KST - Know Sure Thing
MACD Histogram
Mass Index
MFI - Money Flow Index
OBV - On Balance Volume
PPO - Percentage Price Oscillator
PVO - Percentage Volume Oscillator
ROC - Rate Of Change
Standard Deviation - Volatility
Stochastics RSI
Support and Resistance
TRIX
TSI - True Strength Index
Ulcer Index
Ultimate Oscillator
Volume by Price
VTX - Vortex Indicator
Williams % R
Chart Setup 1
Chart Setup 2
Chart Patterns 1
Chart Patterns 2 The Best Bullish and Bearish Patterns
Choosing Indicators
Best part is that it's all FREE!
So what are you waiting for - Get started now!
$SANP CANOE POOL MERGER! WORTH ABOUT $3 BILLION AS OF TODAY'S VALUATION? #BITCOINS #BTC $6,138.00 #CRYPTOCURRENCY
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135197231
Ulcer Index Video
WATCH VIDEO - CLICK HERE <-
Learn all aspects of trading penny stocks in Chart School, Videos include;
Accumulation Distribution
ADX - Average Directional Index
Aroon
ATR - Average True Range
Bollinger %B
Bollinger Band Width
CCI - Commodity Channel Index
Chaikin Oscillator
CMF - Chaikin Money Flow
Coppock Curve
Correlation Coefficient
EMV- Ease of Movement
Fibonacci Retracement
Force Index
KST - Know Sure Thing
MACD Histogram
Mass Index
MFI - Money Flow Index
OBV - On Balance Volume
PPO - Percentage Price Oscillator
PVO - Percentage Volume Oscillator
ROC - Rate Of Change
Standard Deviation - Volatility
Stochastics RSI
Support and Resistance
TRIX
TSI - True Strength Index
Ulcer Index
Ultimate Oscillator
Volume by Price
VTX - Vortex Indicator
Williams % R
Chart Setup 1
Chart Setup 2
Chart Patterns 1
Chart Patterns 2 The Best Bullish and Bearish Patterns
Choosing Indicators
Best part is that it's all FREE!
So what are you waiting for - Get started now!
RTKH PPS .18 +33% YESTERDAY VS 3.30$ BOOK VALUE EX NASDAQ NOW OTCQB OS 24M TINY FLOAT ACTIVIST INVESTOR OWNS MORE THAN 12% WAS 3.50$ IN FEBRUARY NOW .18 BUT RUMORS ABOUT ASSET SALE WORTH 75MLN$ EMERGED IN LATE SEPTEMBER LIFT STOCK TO 0.50$, EASY TRIPLE HERE WHEN AND IF NEWS OUT, COMPANY IS ASSESSING STRATEGIC ALTERNATIVES INCLUDING SALE OR MERGER, BOOK VALUE WORTH 78MLN$ ACCORDING LATEST FINANCIAL RESULTS WHILE MARKET CAP ONLY 4 MLN$!!!
Fibonacci Retracement Video
WATCH VIDEO - CLICK HERE <-
Learn all aspects of trading penny stocks in Chart School, Videos include;
Accumulation Distribution
ADX - Average Directional Index
Aroon
ATR - Average True Range
Bollinger %B
Bollinger Band Width
CCI - Commodity Channel Index
Chaikin Oscillator
CMF - Chaikin Money Flow
Coppock Curve
Correlation Coefficient
EMV- Ease of Movement
Fibonacci Retracement
Force Index
KST - Know Sure Thing
MACD Histogram
Mass Index
MFI - Money Flow Index
OBV - On Balance Volume
PPO - Percentage Price Oscillator
PVO - Percentage Volume Oscillator
ROC - Rate Of Change
Standard Deviation - Volatility
Stochastics RSI
Support and Resistance
TRIX
TSI - True Strength Index
Ulcer Index
Ultimate Oscillator
Volume by Price
VTX - Vortex Indicator
Williams % R
Chart Setup 1
Chart Setup 2
Chart Patterns 1
Chart Patterns 2 The Best Bullish and Bearish Patterns
Choosing Indicators
Best part is that it's all FREE!
So what are you waiting for - Get started now!
$PMCB PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer PMCB
http://www.businesswire.com/news/home/20171017005486/en/PharmaCyte-Biotech-Research-Identifies-Enzyme-Activity-Cannabinoid-Based
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its research partner, the University of Northern Colorado (UNC), has identified an organism whose genome contains the genetic code for production of an enzyme capable of activating a cannabinoid prodrug into its active cancer-killing form.
“We are pleased that UNC has taken us one step closer to developing cannabinoid-based therapies to combat cancer utilizing our proprietary Cell-in-a-Box® live-cell encapsulation technology”
Tweet this
“We are pleased that UNC has taken us one step closer to developing cannabinoid-based therapies to combat cancer utilizing our proprietary Cell-in-a-Box® live-cell encapsulation technology,” commented PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner. “PharmaCyte’s innovative Cannabis Program has established PharmaCyte as a serious player in the medical Cannabis sector, and we are exploring additional strategic relationships to advance product development and commercialization.”
PharmaCyte’s Cannabis Program has had two primary areas of focus. The first is confirming the anti-cancer activity of cannabinoids (constituents of the Cannabis plant), such as tetrahydrocannabinol (THC) and cannabidiol (CBD). UNC’s research has confirmed that a purified cannabinoid showed a potent dose-dependent decrease in cell viability for various cancers, suggesting that this cannabinoid exhibits significant anti-proliferative effects (stops the growth of cancer cells). This activity has been demonstrated in glioblastoma (brain), pancreatic, breast, lung, colon and melanoma cancer cell lines.
The second area of focus is in finding an enzyme capable of converting an inactive, side-effect-free, cannabinoid prodrug into its active cancer-killing form. The research team at UNC has screened numerous cell lines and numerous enzymes. As result of this extensive work, an organism has been identified that has been confirmed to produce an enzyme capable of catalyzing the desired cannabinoid-prodrug-activating reaction. Work is now underway to locate the enzyme’s gene.
Dr. Mark L. Rabe, PharmaCyte’s Director of Cannabis Program Development, commented, “Our work at UNC continues to bear fruit. The work with cancer cell lines not only confirmed cannabinoid anti-cancer activity, it generated important dosing data. The work to identify the needed activating enzyme has been intensive and time-consuming, and we are pleased to have identified a front-running candidate that has exhibited the desired activity.”
Once the location of the activating enzyme gene has been determined within the organism’s genome, a series of steps will occur to amplify and clone the gene and confirm its activity. The gene will then be used to bio-engineer a human cell line that will then become a cannabinoid-prodrug-activating enzyme “factory.” Importantly, the parental human cell line that will be utilized is the same cell line being utilized in PharmaCyte’s therapy for pancreatic cancer. Upon confirmation of the desired activity by the bio-engineered cell line, the final steps include live-cell encapsulation with the Cell-in-a-Box® technology and validation.
Clinically, targeted cannabinoid-based chemotherapy would be accomplished by implanting the encapsulated bio-engineered cells near the site of a tumor, along with administration of a cannabinoid prodrug which would become activated at the site of the tumor by an enzyme produced by the encapsulated cells. The end goal is better efficacy than existing therapies with few, if any, side effects.
About PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. For pancreatic cancer, these encapsulated cells are implanted in the blood supply to the patient’s tumor as close as possible to the site of the tumor. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide flows through pores in the capsules, the live cells inside act as a “bio-artificial liver” and activate the chemotherapy drug at the site of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no treatment related side effects.
PharmaCyte’s therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes involves encapsulating a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient, they will function as a “bio-artificial pancreas” for purposes of insulin production.
Safe Harbor
This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement because of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements due to the impact of numerous risk factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.
More information about PharmaCyte Biotech can be found at www.PharmaCyte.com. Information may also be obtained by contacting PharmaCyte’s Investor Relations Department.
Contacts
Investor Relations:
PharmaCyte Biotech, Inc.
Dr. Gerald W. Crabtree
Investor Relations Department
917.595.2856
Info@PharmaCyte.com
ROC - Rate Of Change Video
WATCH VIDEO - CLICK HERE <-
Learn all aspects of trading penny stocks in Chart School, Videos include;
Accumulation Distribution
ADX - Average Directional Index
Aroon
ATR - Average True Range
Bollinger %B
Bollinger Band Width
CCI - Commodity Channel Index
Chaikin Oscillator
CMF - Chaikin Money Flow
Coppock Curve
Correlation Coefficient
EMV- Ease of Movement
Fibonacci Retracement
Force Index
KST - Know Sure Thing
MACD Histogram
Mass Index
MFI - Money Flow Index
OBV - On Balance Volume
PPO - Percentage Price Oscillator
PVO - Percentage Volume Oscillator
ROC - Rate Of Change
Standard Deviation - Volatility
Stochastics RSI
Support and Resistance
TRIX
TSI - True Strength Index
Ulcer Index
Ultimate Oscillator
Volume by Price
VTX - Vortex Indicator
Williams % R
Chart Setup 1
Chart Setup 2
Chart Patterns 1
Chart Patterns 2 The Best Bullish and Bearish Patterns
Choosing Indicators
Best part is that it's all FREE!
So what are you waiting for - Get started now!
NWPN
Share Structure
Authorized: 1.2 billion
Outstanding Shares: 363 million
Restricted: 300 million
Float : 5,401,716
Par Value: 0.0001
http://www.thenowcorporation.net/
Share Structure
Authorized Shares 1,250,000,000 a/o Jan 10, 2017
Outstanding Shares 391,251,716 a/o Jan 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 90,697,356 a/o Jan 10, 2017
NWPN next salami hit
Big news coming. After current
Small float
Daily Candlestick Chart for MYFT
[img]stockcharts.com/c-sc/sc?s=MYFT
Analyst Bias
The majority of the information that goes into the analysis comes from the company itself. Companies employ investor relations managers specifically to handle the analyst community and release information. As Mark Twain said, "there are lies, damn lies, and statistics." When it comes to massaging the data or spinning the announcement, CFOs and investor relations managers are professionals. Only buy-side analysts tend to venture past the company statistics. Buy-side analysts work for mutual funds and money managers. They read the reports written by the sell-side analysts who work for the big brokers (CIBC, Merrill Lynch, Robertson Stephens, CS First Boston, Paine Weber, DLJ to name a few). These brokers are also involved in underwriting and investment banking for the companies. Even though there are restrictions in place to prevent a conflict of interest, brokers have an ongoing relationship with the company under analysis. When reading these reports, it is important to take into consideration any biases a sell-side analyst may have. The buy-side analyst, on the other hand, is analyzing the company purely from an investment standpoint for a portfolio manager. If there is a relationship with the company, it is usually on different terms. In some cases this may be as a large shareholder.
Daily Candlestick Chart for GFPOF
[img]stockcharts.com/c-sc/sc?s=GFPOF
How Are Charts Formed?
We will be explaining the construction of line, bar, candlestick and point
Daily Candlestick Chart for TIRXF
[img]stockcharts.com/c-sc/sc?s=TIRXF
Daily Candlestick Chart for EFTI
[img]stockcharts.com/c-sc/sc?s=EFTI
What is a small-cap stock? Mid-cap? Large-cap?
These terms refer to a company's market capitalization, which is the number of outstanding shares times the stock's price.
Small cap: $250 Million to $2 Billion, approximately
Mid cap: $2 Billion to $10 Billion, approximately
Large cap: $10 Billion and up, approximately
British Industrial Production: Release Schedule: 8:30 (GMT); monthly, usually 26 working days following the reporting month's end
Revisions Schedule: Monthly revisions made to adjust for incomplete data.
Source of Report: Office for National Statistics (UK)
Web Address: http://www.statistics.gov.uk/default.asp
Address of release: http://www.statistics.gov.uk/statbase/Product.asp?vlnk=6230
Daily Candlestick Chart for TDEY
[img]stockcharts.com/c-sc/sc?s=TDEY
Daily Candlestick Chart for FTCH
[img]stockcharts.com/c-sc/sc?s=FTCH
Short Selling Process
Here is the process:
Request the short sell from your brokerage.
Your brokerage will lend you the shares, if they have them available. It's not uncommon for the shares to be unavailable.
Your brokerage will immediately try to sell the shares on the stock market.
Cash from the sale goes into a special short-sell account that you cannot access. It is used as collateral for the shares that you borrowed.
Wait for the stock to go down.
Finish the trade by choosing "Buy to Cover." This action will buy shares from the market and return them to your brokerage. You will have made a profit if your short sale price was higher than your buy back price (minus any commissions).
Note that your brokerage may request that you return the shares at any time. They may need to return the shares to other customers.
Biflation: Biflation is a phenomenon where both inflation and deflation occur at the same time. This term was coined by Dr. Osborne Brown, a Senior Financial Analyst for the Phoenix Investment group.
During biflation, the prices of commodities and earnings-based assets (equities) rise while the prices of debt-based assets (bonds) fall
Daily Candlestick Chart for OREO
[img]stockcharts.com/c-sc/sc?s=OREO
Bearish Reversal Candlestick Patterns: The Bearish Reversal Candlestick Pattern comes in over 12 different forms. These include the Abandoned Baby, the Bearish Engulfing Pattern, the Harami, the Dark Cloud Cover, the Evening Star and the Shooting Star. Bearish Reversal Candlestick Patterns should form in an uptrend and most will require Bearish Confirmation as reinforcement of the pattern. Use additional anaylsis to further support your findings.
Daily Candlestick Chart for NWSZF
[img]stockcharts.com/c-sc/sc?s=NWSZF
General Steps to Technical Evaluation
Many technicians employ a top-down approach that begins with broad-based macro analysis. The larger parts are then broken down to base the final step on a more focused/micro perspective. Such an analysis might involve three steps:
Broad market analysis through the major indices such as the S
Daily Candlestick Chart for APXG
[img]stockcharts.com/c-sc/sc?s=APXG
Scale Settings
High points and low points appear to line up better for trend lines when prices are displayed using a semi-log scale. This is especially true when long-term trend lines are being drawn or when there is a large change in price. Most charting programs allow users to set the scale as arithmetic or semi-log. An arithmetic scale displays incremental values (5,10,15,20,25,30) evenly as they move up the y-axis. A $10 movement in price will look the same from $10 to $20 or from $100 to $110. A semi-log scale displays incremental values in percentage terms as they move up the y-axis. A move from $10 to $20 is a 100% gain, and would appear to be a much larger than a move from $100 to $110, which is only a 10% gain.
In the case of EMC, there was a large price change over a long period of time. While there were not any false breaks below the uptrend line on the arithmetic scale, the rate of ascent appears smoother on the semi-log scale. EMC doubled three times in less than two years. On the semi-log scale, the trend line fits all the way up. On the arithmetic scale, three different trend lines were required to keep pace with the advance.
In the case of Amazon.com (AMZN), there were two false breaks above the downtrend line as the stock declined during 2000 and 2001. These false break outs could have led to premature buying as the stock continued to decline after each one. The stock lost 60% of its value three times over a two year period. The semi-log scale reflects the percentage loss evenly, and the downtrend line was never broken.
Daily Candlestick Chart for FRCN
[img]stockcharts.com/c-sc/sc?s=FRCN
After each bounce off support, the stock traded all the way up to resistance. Resistance was first established by the September support break at 42.5. After a support level is broken, it can turn into a resistance level. From the October lows, the stock advanced to the new support-turned-resistance level around 42.5. When the stock failed to advance past 42.5, the resistance level was confirmed. The stock subsequently traded up to 42.5 two more times after that and failed to surpass resistance both times.
Daily Candlestick Chart for HOKU
[img]stockcharts.com/c-sc/sc?s=HOKU
Line Chart
Some investors and traders consider the closing level to be more important than the open, high or low. By paying attention to only the close, intraday swings can be ignored. Line charts are also used when open, high and low data points are not available. Sometimes only closing data are available for certain indices, thinly traded stocks and intraday prices.
Daily Candlestick Chart for IWSY
[img]stockcharts.com/c-sc/sc?s=IWSY
Bullish Reversal Candlestick Patterns: The Bullish Reversal Candlestick Pattern has over 14 different pattern styles. These include the Bullish Engulfing, the Piercing Pattern, the Harami, the Hammer, the Inverted Hammer, the Morning Star, and the Abandoned Baby. To use Bullish Reversal Candlestick Patterns succesfully, look for the pattern in a downtrend and use Bullish Confirmation to validate your analysis. Further reinforce your results by using additional analysis to confirm the patterns.
Daily Candlestick Chart for TGLO
[img]stockcharts.com/c-sc/sc?s=TGLO
Descending Trendline: Descending trendlines are a variety of trendlines, one of the most fundamental tools for technical analysis. Descending trendlines are simply trendlines with a negative slope, indicating falling prices. There are two types of descending trendlines: descending top trendlines, in which the high prices for an asset are falling, and descending bottom trendlines, in which the low prices for the asset are falling.
The rules for trading using descending trendlines are the same as the rules for trading with trendlines in general. A descending top trendline is a measure of the resistance to an asset's price, and traders consider a break in price through the descending top to be buy signal for the asset. A descending bottom trendline is a measure of the support in an asset's price, and traders consider a break in price through the descending bottom to be a sell signal for the asset. Many traders consider it necessary for additional signals to appear on the chart before a broken descending trendline is confirmed, and before those traders will take the appropriate market action.
Runaway Gaps
Runaway gaps are also called measuring gaps, and are best described as gaps that are caused by increased interest in the stock. For runaway gaps to the upside, it usually represents traders who did not get in during the initial move of the up trend and while waiting for a retracement in price, decided it was not going to happen. Increased buying interest happens all of a sudden, and the price gaps above the previous day's close. This type of runaway gap represents an almost panic state in traders. Also, a good uptrend can have runaway gaps caused by significant news events that cause new interest in the stock. In the chart below, note the significant increase in volume during and after the runaway gap.
Ford Motor Co. (F) Runaway Gap example chart from StockCharts.com
Runaway gaps can also happen in downtrends. This usually represents increased liquidation of that stock by traders and buyers who are standing on the sidelines. These can become very serious as those who are holding onto the stock will eventually panic and sell – but sell to whom? The price has to continue to drop and gap down to find buyers. Not a good situation.
The term measuring gap is also used for runaway gaps. This is an interpretation that is hard to find examples for, but it is a way of helping one decide how much longer a trend will last. The theory is that the measuring gap will occur in the middle of, or half way through, the move.
Sometimes, the futures market will have runaway gaps that are caused by trading limits imposed by the exchanges. Getting caught on the wrong side of the trend when you have these limit moves in futures can be horrifying. The good news is that you can also be on the right side of them. These are not common occurrences in the futures market despite all the wrong information being touted by those who do not understand it, and are only repeating something they read from an uninformed reporter.
Daily Candlestick Chart for SGLB
[img]stockcharts.com/c-sc/sc?s=SGLB
Daily Candlestick Chart for HLNT
[img]stockcharts.com/c-sc/sc?s=HLNT
Followers
|
3289
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2804248
|
Created
|
08/22/10
|
Type
|
Free
|
Moderator Nilbud | |||
Assistants mick ManicTrader PhotoChick Kirimi $Pistol Pete$ |
Investor Hub Alerts: Sign up for 'STOCKGOODIES PLAYS OF THE WEEK ' E-Mail List UPDATE; 5-1-22 courtesy of charting /\ wit tweezer top calls /\ Tony @Montana_Trades Really good study sheet on Candlestick Patterns [-chart]pbs.twimg.com/media/FRn8188XMAAdZvk?format=jpg&name=small[/chart]
02-07-2021
|
Posts Today
|
0
|
Posts (Total)
|
2804248
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |